You are here: Industry Insights > US

News List

DRL launches muscle disease drug in US financialexpress
September 13, 2018
The company’s product is the generic version of Bloxiverz Injection
Bio processing and manufacturing league table ranks US top and China bottom cphi-online
September 12, 2018
US, Germany and Japan revealed as tier one nations in all categories with Sweden ranking the best of the rest.
New US legislation aims to expedite development of non-opioid pain drugs pharmaphorum
September 12, 2018
The US Senate looks set to pass a set of laws designed to tackle the country’s opioid crisis, encouraging research into non-addictive painkillers, as well as preventing opioids entering the country from China through the mail.
Sanofi Reaches Civil Settlement with US SEC americanpharmaceuticalreview
September 06, 2018
Sanofi has reached a civil settlement with the U.S. Securities and Exchange Commission (SEC) fully resolving the SEC's investigation into possible violations of the U.S. Foreign Corrupt Practices Act.
Indivior shares soar as US judge rules against Dr Reddy pharmafile
July 17, 2018
Shares in the London listed addiction specialist Indivior surged in price today, as the Indian pharmaceutical company Dr Reddy’s Laboratories was blocked from selling generic versions of Indivior’s bestselling opioid addiction treatment, Suboxone Film, in
Takeda gets US nod for Shire buy pharmatimes
July 16, 2018
Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire.
Roche’s Venclexta filed in the US for acute myeloid leukemia pharmatimes
July 16, 2018
The submission is seeking approval for use of the drug, in combination with a hypomethylating agent or in combination with low dose cytarabine (LDAC), for treatment of people with previously untreated AML who are ineligible for intensive chemotherapy.
Novartis and Sandoz withdraw medicines from US over packaging concerns pharmaceutical-technology
July 12, 2018
Novartis and its affiliated Sandoz division have voluntarily recalled certain lots of 12 blister packs of medicines from the US market as the packaging did not meet US federal requirements.
US researchers develop new technique for side effect-free drugs pharmaceutical-technology
July 12, 2018
Researchers at the University of Virginia (UVA) have developed a new approach to facilitate the formulation of safer, effective and side effect-free drugs.
AbbVie ordered to pay $448m over generic delays pharmafile
July 06, 2018
he ruling made in Philadelphia by US District Judge Harvey Bartle acted to conclude an anti-trust lawsuit first filed in 2014 by the Federal Trade Commission against AbbVie and its partner Besins Healthcare.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page